Glycemic control and prostate cancer progression: Results from the SEARCH database

Howard S. Kim, Joseph C. Presti, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling, Stephen J. Freedland

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

PURPOSE Several studies have examined the association between diabetes mellitus (DM) and prostate cancer (PCa) risk and progression, however nearly all of these studies have compared diabetic versus non-diabetic men. We sought to investigate the role of glycemic control, as measured by HbA1c, on PCa aggressiveness and prognosis in men with DM and PCa from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. METHODS We identified 247 men in SEARCH with DM and a recorded HbA1c value within the 12 months prior to radical prostatectomy between 1988 and 2009. We divided these men into tertiles by HbA1c level. The associations between HbA1c tertiles and risk of adverse pathology and biochemical recurrence were tested using multivariate logistic regression and Cox proportional hazards models, respectively. RESULTS Median HbA1c level was 6.9. On multivariate analysis, HbA1c tertiles were predictive of pathological Gleason score (P-trend = 0.001). Relative to the first tertile, men in the second (OR 4.68, P = 0.003) and third tertile (OR 6.60, P < 0.001) were more likely to have Gleason score ≥4 + 3. HbA1c tertiles were not associated with margin status, node status, extracapsular extension or seminal vesicle invasion (all P-trend > 0.2). In the multivariate Cox proportional hazards model, increasing HbA1c tertiles were not significantly related to risk of biochemical recurrence (P-trend = 0.56). CONCLUSION Men with higher HbA1c levels presented with more biologically aggressive prostate tumors at radical prostatectomy. Although risk of recurrence was unrelated to HbA1c levels, further studies are needed to better explore the importance of glycemic control on long-term outcomes in diabetic men with PCa.

Original languageEnglish (US)
Pages (from-to)1540-1546
Number of pages7
JournalProstate
Volume70
Issue number14
DOIs
StatePublished - Oct 1 2010

Fingerprint

Cancer Care Facilities
Prostatic Neoplasms
Databases
Diabetes Mellitus
Prostatectomy
Proportional Hazards Models
Recurrence
Neoplasm Grading
Prostate
Multivariate Analysis
Logistic Models
Pathology

Keywords

  • Diabetes
  • Hba1c
  • Prostate cancer

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Kim, H. S., Presti, J. C., Aronson, W. J., Terris, M. K., Kane, C. J., Amling, C. L., & Freedland, S. J. (2010). Glycemic control and prostate cancer progression: Results from the SEARCH database. Prostate, 70(14), 1540-1546. https://doi.org/10.1002/pros.21189

Glycemic control and prostate cancer progression : Results from the SEARCH database. / Kim, Howard S.; Presti, Joseph C.; Aronson, William J.; Terris, Martha K.; Kane, Christopher J.; Amling, Christopher L.; Freedland, Stephen J.

In: Prostate, Vol. 70, No. 14, 01.10.2010, p. 1540-1546.

Research output: Contribution to journalArticle

Kim, HS, Presti, JC, Aronson, WJ, Terris, MK, Kane, CJ, Amling, CL & Freedland, SJ 2010, 'Glycemic control and prostate cancer progression: Results from the SEARCH database', Prostate, vol. 70, no. 14, pp. 1540-1546. https://doi.org/10.1002/pros.21189
Kim HS, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL et al. Glycemic control and prostate cancer progression: Results from the SEARCH database. Prostate. 2010 Oct 1;70(14):1540-1546. https://doi.org/10.1002/pros.21189
Kim, Howard S. ; Presti, Joseph C. ; Aronson, William J. ; Terris, Martha K. ; Kane, Christopher J. ; Amling, Christopher L. ; Freedland, Stephen J. / Glycemic control and prostate cancer progression : Results from the SEARCH database. In: Prostate. 2010 ; Vol. 70, No. 14. pp. 1540-1546.
@article{24b9d8bf258d47f18b801714272ca63a,
title = "Glycemic control and prostate cancer progression: Results from the SEARCH database",
abstract = "PURPOSE Several studies have examined the association between diabetes mellitus (DM) and prostate cancer (PCa) risk and progression, however nearly all of these studies have compared diabetic versus non-diabetic men. We sought to investigate the role of glycemic control, as measured by HbA1c, on PCa aggressiveness and prognosis in men with DM and PCa from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. METHODS We identified 247 men in SEARCH with DM and a recorded HbA1c value within the 12 months prior to radical prostatectomy between 1988 and 2009. We divided these men into tertiles by HbA1c level. The associations between HbA1c tertiles and risk of adverse pathology and biochemical recurrence were tested using multivariate logistic regression and Cox proportional hazards models, respectively. RESULTS Median HbA1c level was 6.9. On multivariate analysis, HbA1c tertiles were predictive of pathological Gleason score (P-trend = 0.001). Relative to the first tertile, men in the second (OR 4.68, P = 0.003) and third tertile (OR 6.60, P < 0.001) were more likely to have Gleason score ≥4 + 3. HbA1c tertiles were not associated with margin status, node status, extracapsular extension or seminal vesicle invasion (all P-trend > 0.2). In the multivariate Cox proportional hazards model, increasing HbA1c tertiles were not significantly related to risk of biochemical recurrence (P-trend = 0.56). CONCLUSION Men with higher HbA1c levels presented with more biologically aggressive prostate tumors at radical prostatectomy. Although risk of recurrence was unrelated to HbA1c levels, further studies are needed to better explore the importance of glycemic control on long-term outcomes in diabetic men with PCa.",
keywords = "Diabetes, Hba1c, Prostate cancer",
author = "Kim, {Howard S.} and Presti, {Joseph C.} and Aronson, {William J.} and Terris, {Martha K.} and Kane, {Christopher J.} and Amling, {Christopher L.} and Freedland, {Stephen J.}",
year = "2010",
month = "10",
day = "1",
doi = "10.1002/pros.21189",
language = "English (US)",
volume = "70",
pages = "1540--1546",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "14",

}

TY - JOUR

T1 - Glycemic control and prostate cancer progression

T2 - Results from the SEARCH database

AU - Kim, Howard S.

AU - Presti, Joseph C.

AU - Aronson, William J.

AU - Terris, Martha K.

AU - Kane, Christopher J.

AU - Amling, Christopher L.

AU - Freedland, Stephen J.

PY - 2010/10/1

Y1 - 2010/10/1

N2 - PURPOSE Several studies have examined the association between diabetes mellitus (DM) and prostate cancer (PCa) risk and progression, however nearly all of these studies have compared diabetic versus non-diabetic men. We sought to investigate the role of glycemic control, as measured by HbA1c, on PCa aggressiveness and prognosis in men with DM and PCa from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. METHODS We identified 247 men in SEARCH with DM and a recorded HbA1c value within the 12 months prior to radical prostatectomy between 1988 and 2009. We divided these men into tertiles by HbA1c level. The associations between HbA1c tertiles and risk of adverse pathology and biochemical recurrence were tested using multivariate logistic regression and Cox proportional hazards models, respectively. RESULTS Median HbA1c level was 6.9. On multivariate analysis, HbA1c tertiles were predictive of pathological Gleason score (P-trend = 0.001). Relative to the first tertile, men in the second (OR 4.68, P = 0.003) and third tertile (OR 6.60, P < 0.001) were more likely to have Gleason score ≥4 + 3. HbA1c tertiles were not associated with margin status, node status, extracapsular extension or seminal vesicle invasion (all P-trend > 0.2). In the multivariate Cox proportional hazards model, increasing HbA1c tertiles were not significantly related to risk of biochemical recurrence (P-trend = 0.56). CONCLUSION Men with higher HbA1c levels presented with more biologically aggressive prostate tumors at radical prostatectomy. Although risk of recurrence was unrelated to HbA1c levels, further studies are needed to better explore the importance of glycemic control on long-term outcomes in diabetic men with PCa.

AB - PURPOSE Several studies have examined the association between diabetes mellitus (DM) and prostate cancer (PCa) risk and progression, however nearly all of these studies have compared diabetic versus non-diabetic men. We sought to investigate the role of glycemic control, as measured by HbA1c, on PCa aggressiveness and prognosis in men with DM and PCa from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. METHODS We identified 247 men in SEARCH with DM and a recorded HbA1c value within the 12 months prior to radical prostatectomy between 1988 and 2009. We divided these men into tertiles by HbA1c level. The associations between HbA1c tertiles and risk of adverse pathology and biochemical recurrence were tested using multivariate logistic regression and Cox proportional hazards models, respectively. RESULTS Median HbA1c level was 6.9. On multivariate analysis, HbA1c tertiles were predictive of pathological Gleason score (P-trend = 0.001). Relative to the first tertile, men in the second (OR 4.68, P = 0.003) and third tertile (OR 6.60, P < 0.001) were more likely to have Gleason score ≥4 + 3. HbA1c tertiles were not associated with margin status, node status, extracapsular extension or seminal vesicle invasion (all P-trend > 0.2). In the multivariate Cox proportional hazards model, increasing HbA1c tertiles were not significantly related to risk of biochemical recurrence (P-trend = 0.56). CONCLUSION Men with higher HbA1c levels presented with more biologically aggressive prostate tumors at radical prostatectomy. Although risk of recurrence was unrelated to HbA1c levels, further studies are needed to better explore the importance of glycemic control on long-term outcomes in diabetic men with PCa.

KW - Diabetes

KW - Hba1c

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=77957013460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957013460&partnerID=8YFLogxK

U2 - 10.1002/pros.21189

DO - 10.1002/pros.21189

M3 - Article

C2 - 20687228

AN - SCOPUS:77957013460

VL - 70

SP - 1540

EP - 1546

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 14

ER -